|
1
|
Lee JH, Kim HI, Kim MG, Ha TK, Jung MS and
Kwon SJ: Recurrence of gastric cancer in patients who are
disease-free for more than 5 years after primary resection.
Surgery. 159:1090–1098. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sitohy B, Nagy JA and Dvorak HF:
Anti-VEGF/VEGFR therapy for cancer: Reassessing the target. Cancer
Res. 72:1909–1914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pinto MP, Sotomayor P, Carrasco-Avino G,
Corvalan AH and Owen GI: Escaping antiangiogenic therapy:
Strategies employed by cancer cells. Int J Mol Sci. 17:2016.
View Article : Google Scholar
|
|
4
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seftor RE, Hess AR, Seftor EA, Kirschmann
DA, Hardy KM, Margaryan NV and Hendrix MJ: Tumor cell vasculogenic
mimicry: From controversy to therapeutic promise. Am J Pathol.
181:1115–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Gu Y, Zhang Z, Zhang S, Zhang D,
Saleem AF, Zhao X and Sun B: Vasculogenic mimicry: A new prognostic
sign of gastric adenocarcinoma. Pathol Oncol Res. 16:259–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakamura R, Kataoka H, Sato N, Kanamori M,
Ihara M, Igarashi H, Ravshanov S, Wang YJ, Li ZY, Shimamura T, et
al: EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci.
96:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wykosky J and Debinski W: The EphA2
receptor and ephrinA1 ligand in solid tumors: Function and
therapeutic targeting. Mol Cancer Res. 6:1795–1806. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan WJ, Ge J, Chen ZK, Wu SB, Shen H,
Yang P, Hu B, Zhang GW and Chen ZH: Over-expression of EphA2 and
EphrinA-1 in human gastric adenocarcinoma and its prognostic value
for postoperative patients. Dig Dis Sci. 54:2410–2417. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brantley-Sieders DM, Fang WB, Hwang Y,
Hicks D and Chen J: Ephrin-A1 facilitates mammary tumor metastasis
through an angiogenesis-dependent mechanism mediated by EphA
receptor and vascular endothelial growth factor in mice. Cancer
Res. 66:10315–10324. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng N, Brantley DM, Liu H, Lin Q,
Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO and Chen
J: Blockade of EphA receptor tyrosine kinase activation inhibits
vascular endothelial cell growth factor-induced angiogenesis. Mol
Cancer Res. 1:2–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang W, Lin P, Sun B, Zhang S, Cai W, Han
C, Li L, Lu H and Zhao X: Epithelial-mesenchymal transition
regulated by EphA2 contributes to vasculogenic mimicry formation of
head and neck squamous cell carcinoma. Biomed Res Int.
2014:8039142014.PubMed/NCBI
|
|
13
|
Ding X, Xi W, Ji J, Cai Q, Jiang J, Shi M,
Yu Y, Zhu Z and Zhang J: HGF derived from cancer-associated
fibroblasts promotes vascularization in gastric cancer via PI3K/AKT
and ERK1/2 signaling. Oncol Rep. 40:1185–1195. 2018.PubMed/NCBI
|
|
14
|
Hong HN, Won YJ, Shim JH, Kim HJ, Han SH,
Kim BS and Kim HS: Cancer-associated fibroblasts promote gastric
tumorigenesis through EphA2 activation in a ligand-independent
manner. J Cancer Res Clin Oncol. 144:1649–1663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Japanese classification of gastric
carcinoma: 3rd English edition. Gastric cancer: Official journal of
the International Gastric Cancer Association and the Japanese
Gastric Cancer Association, . 14:101–112. 2011.
|
|
16
|
Kwon SJ: Evaluation of the 7th UICC TNM
staging system of gastric cancer. J Gastric Cancer. 11:78–85. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou Z, Yuan X, Li Z, Tu H, Li D, Qing J,
Wang H and Zhang L: RNA interference targeting EphA2 inhibits
proliferation, induces apoptosis, and cooperates with cytotoxic
drugs in human glioma cells. Surg Neurol. 70:562–568; discussion
568-569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moccia M, Liu Q, Guida T, Federico G,
Brescia A, Zhao Z, Choi HG, Deng X, Tan L, Wang J, et al:
Identification of novel small molecule inhibitors of oncogenic RET
kinase. PLoS One. 10:e01283642015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amato KR, Wang S, Hastings AK, Youngblood
VM, Santapuram PR, Chen H, Cates JM, Colvin DC, Ye F,
Brantley-Sieders DM, et al: Genetic and pharmacologic inhibition of
EPHA2 promotes apoptosis in NSCLC. J Clin Invest. 124:2037–2049.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuyuhiro Y, Yashiro M, Noda S, Matsuoka J,
Hasegawa T, Kato Y, Sawada T and Hirakawa K: Cancer-associated
orthotopic myofibroblasts stimulates the motility of gastric
carcinoma cells. Cancer Sci. 103:797–805. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhi K, Shen X, Zhang H and Bi J:
Cancer-associated fibroblasts are positively correlated with
metastatic potential of human gastric cancers. J Exp Clin Cancer
Res. 29:662010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu B, Chen X, Li J, Qu Y, Su L, Peng Y,
Huang J, Yan J, Yu Y, Gu Q, et al: Stromal fibroblasts in the
microenvironment of gastric carcinomas promote tumor metastasis via
upregulating TAGLN expression. BMC Cell Biol. 14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW,
Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional
significance of Twist1 in hepatocellular carcinoma: Its role in
vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu K, Sun B, Zhao X, Wang X, Li Y, Qiu Z,
Gu Q, Dong X, Zhang Y, Wang Y and Zhao N: Hypoxia induced
epithelial-mesenchymal transition and vasculogenic mimicry
formation by promoting Bcl-2/Twist1 cooperation. Exp Mol Pathol.
99:383–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hess AR, Seftor EA, Gardner LM,
Carles-Kinch K, Schneider GB, Seftor RE, Kinch MS and Hendrix MJ:
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine
phosphorylation: Role of epithelial cell kinase (Eck/EphA2). Cancer
Res. 61:3250–3255. 2001.PubMed/NCBI
|
|
27
|
Wang H, Sun W, Zhang WZ, Ge CY, Zhang JT,
Liu ZY and Fan YZ: Inhibition of tumor vasculogenic mimicry and
prolongation of host survival in highly aggressive gallbladder
cancers by norcantharidin via blocking the ephrin type a receptor
2/focal adhesion kinase/paxillin signaling pathway. PLoS One.
9:e969822014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan W and Chen Z, Wu S, Ge J, Chang S,
Wang X, Chen J and Chen Z: Expression of EphA2 and E-cadherin in
gastric cancer: Correlated with tumor progression and lymphogenous
metastasis. Pathol Oncol Res. 15:473–478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou F, Yuan W, Huang J, Qian L and Chen Z,
Ge J, Wu S, Chen J, Wang J and Chen Z: Overexpression of EphA2
correlates with epithelial-mesenchymal transition-related proteins
in gastric cancer and their prognostic importance for postoperative
patients. Med Oncol. 29:2691–2700. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Youngblood V, Wang S, Song W, Walter D,
Hwang Y, Chen J and Brantley-Sieders DM: Elevated Slit2 activity
impairs VEGF-induced angiogenesis and tumor neovascularization in
EphA2-deficient endothelium. Mol Cancer Res. 13:524–537. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miao Z, Dong Y, Fang W, Shang D, Liu D,
Zhang K, Li B and Chen YH: VEGF increases paracellular permeability
in brain endothelial cells via upregulation of EphA2. Anat Rec
(Hoboken). 297:964–972. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen J, Xie B, Hatara CM, Hackett SF and
Campochiaro PA: Vegf or EphA2 antisense polyamide-nucleic acids;
vascular localization and suppression of retinal
neovascularization. Mol Ther. 15:1924–1930. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu L, Zhang YS, Ye ML, Shen F, Liu W, Hu
HS, Li SW, Wu HW, Chen QH and Zhou WB: Overexpression and
correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular
carcinoma following high-intensity focused ultrasound treatment:
Implications for tumor recurrence and progression. Exp Ther Med.
13:3529–3534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang M, Huang B, Li G and Zeng S:
Apatinib affect VEGF-mediated cell proliferation, migration,
invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in
cholangiocarcinoma cell. BMC Gastroenterol. 18:1692018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu XS, Sun W, Ge CY, Zhang WZ and Fan YZ:
Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin
signaling pathways to tumor growth and vasculogenic mimicry of
gallbladder carcinomas. Int J Oncol. 42:2103–2115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Lin H, Pan J, Mo C, Zhang F, Huang
B, Wang Z, Chen X, Zhuang J, Wang D and Qiu S: Vasculogenic mimicry
in prostate cancer: The roles of EphA2 and PI3K. J Cancer.
7:1114–1124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Li F, Yang YT, Xu XD, Chen JS, Chen
TL, Chen HJ, Zhu YB, Lin JY, Li Y, et al: IGFBP2 promotes
vasculogenic mimicry formation via regulating CD144 and MMP2
expression in glioma. Oncogene. 38:1815–1831. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo JQ, Zheng QH, Chen H, Chen L, Xu JB,
Chen MY, Lu D, Wang ZH, Tong HF and Lin S: Ginsenoside Rg3
inhibition of vasculogenic mimicry in pancreatic cancer through
downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression. Int J
Oncol. 45:1065–1072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim HS, Won YJ, Shim JH, Kim HJ, Kim J,
Hong HN and Kim BS: Morphological characteristics of vasculogenic
mimicry and its correlation with EphA2 expression in gastric
adenocarcinoma. Sci Rep. 9:34142019. View Article : Google Scholar : PubMed/NCBI
|
